TY - JOUR
T1 - TRAIL limits excessive host immune responses in bacterial meningitis
AU - Hoffmann, Olaf
AU - Priller, Josef
AU - Prozorovski, Timour
AU - Schulze-Topphoff, Ulf
AU - Baeva, Nevena
AU - Lunemann, Jan D.
AU - Aktas, Orhan
AU - Mahrhofer, Cordula
AU - Stricker, Sarah
AU - Zipp, Frauke
AU - Weber, Joerg R.
PY - 2007/7/2
Y1 - 2007/7/2
N2 - Apart from potential roles in anti-tumor surveillance, the TNF-related apoptosis-inducing ligand (TRAIL) has important regulatory functions in the host immune response. We studied antiinflammatory effects of endogenous and recombinant TRAIL (rTRAIL) in experimental meningitis. Following intrathecal application of pneumococcal cell wall, a TLR2 ligand, we found prolonged inflammation, augmented clinical impairment, and increased apoptosis in the hippocampus of TRAIL-/- mice. Administration of rTRAIL into the subarachnoid space of TRAIL-/- mice or reconstitution of hematopoiesis with wild-type bone marrow cells reversed these effects, suggesting an autoregulatory role of TRAIL within the infiltrating leukocyte population. Importantly, intrathecal application of rTRAIL in wild-type mice with meningitis also decreased inflammation and apoptosis. Moreover, patients suffering from bacterial meningitis showed increased intrathecal synthesis of TRAIL. Our findings provide what we believe is the first evidence that TRAIL may act as a negative regulator of acute CNS inflammation. The ability of TRAIL to modify inflammatory responses and to reduce neuronal cell death in meningitis suggests that it may be used as a novel antiinflammatory agent in invasive infections.
AB - Apart from potential roles in anti-tumor surveillance, the TNF-related apoptosis-inducing ligand (TRAIL) has important regulatory functions in the host immune response. We studied antiinflammatory effects of endogenous and recombinant TRAIL (rTRAIL) in experimental meningitis. Following intrathecal application of pneumococcal cell wall, a TLR2 ligand, we found prolonged inflammation, augmented clinical impairment, and increased apoptosis in the hippocampus of TRAIL-/- mice. Administration of rTRAIL into the subarachnoid space of TRAIL-/- mice or reconstitution of hematopoiesis with wild-type bone marrow cells reversed these effects, suggesting an autoregulatory role of TRAIL within the infiltrating leukocyte population. Importantly, intrathecal application of rTRAIL in wild-type mice with meningitis also decreased inflammation and apoptosis. Moreover, patients suffering from bacterial meningitis showed increased intrathecal synthesis of TRAIL. Our findings provide what we believe is the first evidence that TRAIL may act as a negative regulator of acute CNS inflammation. The ability of TRAIL to modify inflammatory responses and to reduce neuronal cell death in meningitis suggests that it may be used as a novel antiinflammatory agent in invasive infections.
UR - http://www.scopus.com/inward/record.url?scp=34447131406&partnerID=8YFLogxK
U2 - 10.1172/JCI30356
DO - 10.1172/JCI30356
M3 - Article
C2 - 17571163
AN - SCOPUS:34447131406
SN - 0021-9738
VL - 117
SP - 2004
EP - 2013
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 7
ER -